Simon Kim, MD
Professor, Surgery-Urology

Photo
Download CV
Medical School:
  • MD, Chicago Medical School at Rosalind Franklin University of Medicine & Science (2004)
Graduate School :
  • MPH, University of Illinois At Chicago (1997)
Undergraduate School:
  • BA, University of Rochester (NY) (1995)
Internship:
  • University of Michigan Hospitals and Health Centers Program (2005)
Residency:
  • University of Michigan Hospitals and Health Centers Program, Chief Resident, Urology (2010)
Fellowships:
  • College of Medicine, Mayo Clinic (Rochester) Program, Urologic Oncology (2013)
Languages: English
Department: Surgery-Urology

Professional Titles

  • Professor

Recognition & Awards

  • Section Editor for Urologic Oncology, Annals of Surgical Oncology (2023)
  • Faculty Teaching Award, Univeristy of Colorado Division of Urology (2023)
  • Faculty Teaching Award, University of Colorado (2022)
  • Best Reviewer, Urology Practice (2022)
  • Faculty Teaching Award, Univeristy of Colorado Division of Urology (2021)
  • Editorial Board, AME Medical Journal (2019)
  • Core Curriculum Prostate Cancer Screening and Diagnosis, American Urological Association (2018)
  • Management of Localized and Advanced Prostate Cancer, American Urological Association (2018)
  • Assistant Editor, Journal of Urology (2017)
  • Panel Member, National Comprehensive Cancer Network (2015)
    Panel member for Prostate Cancer Early Detection
  • Career Development Award, Conquer Cancer Foundation and ASCO (2014)
    Dr. Kim was awarded a career development award from the Conquer Cancer Foundation and American Society of Clinical Oncology (ASCO) to assess the barriers to active surveillance for low-risk prostate cancer.
  • Best Reviewer, Journal of Urology (2013)
  • Bronze Beeper, University of Michigan Medical School (2005)
    Excellence in teaching
  • Board of Trustees Scholarship, Rosalind Franklin Chicago Medical School (2004)
  • Alpha Omega Alpha Honor Society, Rosalind Franklin Chicago Medical School (2004)
  • Cum Laude, University of Rochester (1995)
  • High Distinction in Health and Society, University of Rochester (1995)

Teaching

  • Associate Program Urology Residency Director (2019)
    School of Medicine, Surgery
  • Site Director (Urology) (2019)
    School of Medicine, University of Colorado - Denver
  • Professor (2022)
    School of Medicine, Surgery
  • Faculty Teaching Award (2023)
    School of Medicine, Surgery

Publications

  • Ballon-Landa E, Kim SP. Editorial Comment. J Urol. 2023 Jan;209(1):167-168. PubMed PMID: 36278266
  • Neilson T, Huynh V, Macdonald A, Romandetti K, Ahrendt G, Hampanda K, Kim SP, Tevis SE. Financial Toxicity of Breast Cancer Care: The Patient Perspective Through Surveys and Interviews. J Surg Res. 2023 Jan;281:122-129. PubMed PMID: 36155269
  • Morton E, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, Kim SP, Bellmunt J, Kaplan I, Olumi AF, Gershman B. Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection. Urol Oncol. 2022 Dec 2. [Epub ahead of print] PubMed PMID: 36470805
  • Schaufler C, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, Kim S, Bellmunt J, Kaplan I, Olumi AF, Gershman B. Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy. Prostate Cancer Prostatic Dis. 2022 Nov 25. [Epub ahead of print] PubMed PMID: 36434164
  • Morrison JC, Kim SP. Author Reply. Urology. 2022 Oct;168:34. PubMed PMID: 36266026
  • Driscoll B, Leonard LD, Kovar A, Billings J, Tevis SE, Kim SP, Cumbler E. Surgeon Perceptions of the Integration of Patient-Reported Outcome Measures into Clinical Practice. J Surg Res. 2022 Dec;280:486-494. PubMed PMID: 36067535
  • Huynh V, Vemuru S, Hampanda K, Pettigrew J, Fasano M, Coons HL, Rojas KE, Afghahi A, Ahrendt G, Kim S, Matlock DD, Tevis SE. ASO Visual Abstract: No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer. Ann Surg Oncol. 2022 Oct;29(10):6252-6253. PubMed PMID: 35963904
  • Huynh V, Vemuru S, Hampanda K, Pettigrew J, Fasano M, Coons HL, Rojas KE, Afghahi A, Ahrendt G, Kim S, Matlock DD, Tevis SE. No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer. Ann Surg Oncol. 2022 Oct;29(10):6238-6251. PubMed PMID: 35915298
  • Bourlon MT, Verduzco-Aguirre H, Molina E, Meyer E, Kessler E, Kim SP, Spiess PE, Flaig T. Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis. Front Oncol. 2022;12:926692. PubMed PMID: 35847850
  • Morrison JC, Sax-Bolder A, Gershman B, Konety B, Clark PE, Gonzalez CM, Bronsert MR, Lloyd G, Pessoa RR, Ballon-Landa E, Kim SP. Geographic Variation of Infectious Complications Following Prostate Biopsy in The United States: Results From a Population-Based Cohort of Privately Insured Patients. Urology. 2022 Oct;168:27-34. PubMed PMID: 35809698
  • Pessoa RR, Kim SP. EDITORIAL COMMENT. Urology. 2022 May;163:118. PubMed PMID: 35636842
  • Anishchenko K, Antoine S, Geiger C, Lenzmeier R, Kim S, Lloyd GL. High-risk Disease and Poor Follow-up: The Importance of Renal Mass Biopsy in a Cohort of Veterans. Urology. 2022 Sep;167:152-157. PubMed PMID: 35588788
  • Kim SP, Tilburt JC. Reply to "How should decision aids be developed, and which patient outcomes should be assessed?". Cancer. 2022 Aug 1;128(15):2990. PubMed PMID: 35507239
  • Bharadwaj M, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, Kim S, Bellmunt J, Kaplan I, Olumi AF, Gershman B. Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder. Urol Oncol. 2022 Jun;40(6):274.e15-274.e23. PubMed PMID: 35307291
  • Millrose M, Gesslein M, Ittermann T, Kim S, Vonderlind HC, Ruettermann M. Arthrodesis of the proximal interphalangeal joint of the finger - a systematic review. EFORT Open Rev. 2022 Jan 11;7(1):49-58. PubMed PMID: 35076414
  • Friedman BJ, Chen I, Asantey K, Loeb S, Kim SP, Malik RD, Karabon P, Wunderlich-Barillas T, Chandrasekar T. Twitter Engagement of Medical Students Applying to Urology Residency During COVID-19: A Mixed Methods Study. Urology. 2022 Jul;165:120-127. PubMed PMID: 35063463
  • Softness K, Kaul S, Fleishman A, Efstathiou J, Bellmunt J, Kim SP, Korets R, Chang P, Wagner A, Olumi AF, Gershman B. Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder. Urol Oncol. 2022 Jun;40(6):272.e1-272.e9. PubMed PMID: 35058142
  • Zinterl I, Ittermann T, Schipf S, Gross S, Anspieler H, Kim S, Ewert R, Bülow R, Kühn JP, Lerch MM, Völzke H, Felix SB, Bahls M, Targher G, Dörr M, Markus MRP. Low cardiopulmonary fitness is associated with higher liver fat content and higher gamma-glutamyltransferase concentrations in the general population - "The Sedentary's Liver". Liver Int. 2022 Mar;42(3):585-594. PubMed PMID: 35020966
  • Tilburt JC, Zahrieh D, Pacyna JE, Petereit DG, Kaur JS, Rapkin BD, Grubb RL 3rd, Chang GJ, Morris MJ, Kovac EZ, Babaian KN, Sloan JA, Basch EM, Peil ES, Dueck AC, Novotny PJ, Paskett ED, Buckner JC, Joyce DD, Montori VM, Frosch DL, Volk RJ, Kim SP. Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD). Cancer. 2022 Mar 15;128(6):1242-1251. PubMed PMID: 34890060
  • Lee V, An Y, Park HS, Yu JB, Kim SP, Jairam V. Emergency department visits for radiation cystitis among patients with a prostate cancer history. BJU Int. 2022 Aug;130(2):208-216. PubMed PMID: 34806813
  • Gleisner AL, Moss A, Friedman C, Suresh K, Grunwald G, Torphy RJ, Leonard LD, Colborn K, Ahrendt G, Tevis S, Christian N, Abud VL, de Araujo TB, Beaty LE, Thieu D, Glorioso TJ, Kim S, Daugherty S. De-implementation of Axillary Dissection in Women With Breast Cancer is Largely Driven By Site-level Contextual Effects. Ann Surg. 2022 Dec 1;276(6):e923-e931. PubMed PMID: 33351462
  • DeWitt-Foy ME, Gam K, Modlin C, Kim SP, Abouassaly R. Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer. J Urol. 2021 Feb;205(2):426-433. PubMed PMID: 33226309
  • DeWitt-Foy ME, Gam K, Modlin C, Kim SP, Abouassaly R. Reply by Authors. J Urol. 2021 Feb;205(2):433. PubMed PMID: 33226307
  • Sarabu N, Schiltz N, Woodside KJ, Huml AM, Sehgal AR, Kim S, Hricik DE. Prostate Cancer, Kidney Transplant Wait Time, and Mortality in Maintenance Dialysis Patients: A Cohort Study Using Linked United States Renal Data System Data. Kidney Med. 2021 Nov-Dec;3(6):1032-1040. PubMed PMID: 34939012
  • Tilburt JC, Zahrieh D, Pacyna JE, Petereit DG, Kaur JS, Rapkin BD, Grubb RL 3rd, Chang GJ, Morris MJ, Kovac EZ, Babaian KN, Sloan JA, Basch EM, Peil ES, Dueck AC, Novotny PJ, Paskett ED, Buckner JC, Joyce DD, Montori VM, Frosch DL, Volk RJ, Kim SP. Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD). Cancer. 2021 Dec 10. [Epub ahead of print] PubMed PMID: 34890060
  • Lee V, An Y, Park HS, Yu JB, Kim SP, Jairam V. Emergency department visits for radiation cystitis among patients with a prostate cancer history. BJU Int. 2021 Nov 22. [Epub ahead of print] PubMed PMID: 34806813
  • Rodriguez-Pessoa R, Cost N, Tevis SE, Kim SP. EDITORIAL COMMENT. Urology. 2021 Oct;156:180. PubMed PMID: 34758555
  • Huynh V, Colborn K, Smith S, Bonnell LN, Ahrendt G, Christian N, Kim S, Matlock DD, Lee C, Tevis SE. Early Trajectories of Patient Reported Outcomes in Breast Cancer Patients Undergoing Lumpectomy Versus Mastectomy. Ann Surg Oncol. 2021 Oct;28(10):5677-5685. PubMed PMID: 34263375
  • Huynh V, Yang J, Bronsert M, Ludwigson A, Ahrendt G, Kim S, Matlock DD, Cohen J, Hampanda K, Tevis SE. Choosing Between Mastectomy and Breast-Conserving Therapy: Is Patient Distress an Influencing Factor?. Ann Surg Oncol. 2021 Dec;28(13):8679-8687. PubMed PMID: 34160707
  • Pessoa RR, Maroni P, Kukreja J, Kim SP. Comparative effectiveness of robotic and open radical prostatectomy. Transl Androl Urol. 2021 May;10(5):2158-2170. PubMed PMID: 34159098
  • Rodrigues Pessoa R, Mueller AC, Boxley P, Flaig TW, Piper C, Konety B, Yu JB, Gershman B, Kukreja J, Kim SP. Systematic review and meta-analysis of radiation therapy for high-risk non-muscle invasive bladder cancer. Urol Oncol. 2021 Nov;39(11):786.e1-786.e8. PubMed PMID: 33846085
  • Rodrigues Pessoa R, Morrison JC, Konety B, Gershman B, Maroni P, Kukreja JB, Cost N, Flaig T, Kessler E, Sharma P, Kim SP. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Urol Oncol. 2021 Dec;39(12):832.e9-832.e15. PubMed PMID: 33820697
  • DeWitt-Foy ME, Gam K, Modlin C, Kim SP, Abouassaly R. Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer. J Urol. 2021 Feb;205(2):426-433. PubMed PMID: 33226309
  • DeWitt-Foy ME, Gam K, Modlin C, Kim SP, Abouassaly R. Reply by Authors. J Urol. 2021 Feb;205(2):433. PubMed PMID: 33226307
  • Puneet K, Tilburt JC, Volk RJ, Bennett CL, Qureshi Z, Gershman B, Sedlacek HM, Kim SP. Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey. Eur J Cancer Care (Engl). 2021 Jan;30(1):e13301. PubMed PMID: 33112008
  • Kim SP, Karnes RJ, Mwangi R, Van Houten H, Gross CP, Gershman B, Leapman MS, Shah ND. Contemporary Trends in Magnetic Resonance Imaging at the Time of Prostate Biopsy: Results from a Large Private Insurance Database. Eur Urol Focus. 2021 Jan;7(1):86-94. PubMed PMID: 31047904
  • Owens OL, Estrada RM, Johnson K, Cogdell M, Fried DB, Gansauer L, Kim S. 'I'm not a chance taker': A mixed methods exploration of factors affecting prostate cancer treatment decision-making. Ethn Health. 2021 Nov;26(8):1143-1162. PubMed PMID: 30987436
  • Javier-DesLoges JF, Yuan J, Soliman S, Hakimi K, Meagher MF, Ghali F, Hsiang W, Patel DN, Kim SP, Murphy JD, Parsons JK, Derweesh IH. Evaluation of Insurance Coverage and Cancer Stage at Diagnosis Among Low-Income Adults With Renal Cell Carcinoma After Passage of the Patient Protection and Affordable Care Act. JAMA Netw Open. 2021 Jul 1;4(7):e2116267. PubMed PMID: 34269808
  • Puneet K, Tilburt JC, Volk RJ, Bennett CL, Qureshi Z, Gershman B, Sedlacek HM, Kim SP. Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey. Eur J Cancer Care (Engl). 2020 Oct 27;:e13301. [Epub ahead of print] PubMed PMID: 33112008
  • Bongiovanni T, Kim SP, Kim A, Killelea B, Gross C. Is there variation in private payor payments to cancer surgeons? A cross-sectional study in the USA. BMJ Open. 2020 Oct 5;10(10):e035438. PubMed PMID: 33020076
  • Cherullo EE, Pessoa RR, Kim SP. EDITORIAL COMMENT. Urology. 2020 Aug;142:104-105. PubMed PMID: 32709438
  • Gershan B, Rodrigues-Pessoa R, Kim SP. Editorial Comment. J Urol. 2020 Oct;204(4):817. PubMed PMID: 32703055
  • Ghabili K, Park HS, Yu JB, Sprenkle PC, Kim SP, Nguyen KA, Ma X, Gross CP, Leapman MS. National trends in the management of patients with positive surgical margins at radical prostatectomy. World J Urol. 2020 Jun 19. [Epub ahead of print] PubMed PMID: 32562045
  • Morrison JC, Lloyd GL, Konety B, Barqawi Z, Kim SP. EDITORIAL COMMENT. Urology. 2020 Jun;140:105-106. PubMed PMID: 32456855
  • Matulay JT, Tabayoyong W, Duplisea JJ, Chang C, Daneshmand S, Gore JL, Holzbeierlein JM, Karsh LI, Kim SP, Konety BR, Li R, McKiernan JM, Messing EM, Steinberg GD, Williams SB, Kamat AM. Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members. Urol Oncol. 2020 Oct;38(10):796.e1-796.e6. PubMed PMID: 32430255
  • Kim SSY, Hamiliton B, Beable S, Cavadino A, Fulcher ML. Elite coaches have a similar prevalence of depressive symptoms to the general population and lower rates than elite athletes. BMJ Open Sport Exerc Med. 2020;6(1):e000719. PubMed PMID: 32341800
  • Gershman B, Bukavina L, Chen Z, Konety B, Schumache F, Li L, Kutikov A, Smaldone M, Abouassaly R, Kim SP. The Association of Robot-assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital Costs. Eur Urol Focus. 2020 Mar 15;6(2):305-312. PubMed PMID: 30361146
  • Bukavina L, Tilburt JC, Konety B, Shah ND, Gross CP, Yu JB, Schumacher F, Kutikov A, Smaldone MC, Kim SP. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey. Eur Urol Focus. 2020 Mar 15;6(2):273-279. PubMed PMID: 30219709
  • Morrison JC, Gershman B, Konety B, Cost N, Kim SP. Centralization of Health Care to Facilitate Greater Use of Nephron-Sparing Surgery for Localized Renal Tumors: Identifying Appropriate Health Care Delivery. Ann Surg Oncol. 2020 Jun;27(6):1735-1736. PubMed PMID: 31974706
  • Gleisner AL, Moss A, Friedman C, Suresh K, Grunwald G, Torphy RJ, Leonard LD, Colborn K, Ahrendt G, Tevis S, Christian N, Abud VL, de Araujo TB, Beaty LE, Thieu D, Glorioso TJ, Kim S, Daugherty S. De-Implementation of Axillary Dissection in Women with Breast Cancer is Largely Driven By Site-Level Contextual Effects. Ann Surg. 2020 Dec 18;Publish Ahead of Print. [Epub ahead of print] PubMed PMID: 33351462
View All (50 Total) View Less

Professional Memberships

  • American Urological Association, Member
  • American Medical Association, Member
  • American Board of Urology, Diplomat
  • American Society of Clinical Oncology, Member
  • European Urological Association, Member
  • Society of Urologic Oncology, Member

Practice Locations

UCHealth Tony Grampsas Urologic Cancer Care Clinic - Anschutz Medical Campus
1665 Aurora Ct
1st Floor
Aurora, CO 80045
720-848-0170

CU Medicine Urologic Oncology - Highlands Ranch Specialty Care Center
1500 Park Central Drive
Suite 201
Highlands Ranch, CO 80129
720-516-1094

UCHealth Surgical Care - Highlands Ranch Hospital
1500 Park Central Drive
Highlands Ranch, CO 80129
720-516-1000

Hospital Affiliation
  • University of Colorado Hospital
  • UCHealth Highlands Ranch Hospital
Center Affiliations

Specialty Information

Specialties
  • Urologic Oncology, Board Certification (2013)
  • Urology, Board Certification (2010)
  • American Board of Urology, Board Certification (2014)
Conditions & Treatments
  • Cancers - Urologic Cancer
  • Cancers
  • Cancers - Testicular Cancer
  • Cancers - Sarcoma
  • Cancers - Prostate Cancer
  • Cancers - Kidney Cancer
  • Cancers - Bladder Cancer
  • Cancers - Cancer Surgery
Clinical Interests
I am a Professor of Urologic Oncology and treat localized and locally advanced kidney, bladder, prostate testicular, penile and adrenal cancer. I strive to provide the highest quality and compassionate care for patients diagnosed with cancer and their family members. I also focus developing a treatment plan that involves patients and their families and individualize treatment plans to achieve the best possible outcome. I perform robotic, open and laparoscopic surgery for bladder, kidney, prostate, testicular, penile and adrenal cancer. He previously served as Director of Robotic Surgery and Director of Kidney and Bladder Cancer at his prior faculty position. I will also coordinate multi-disciplinary care with medical oncologists and radiation oncologists to develops treatment plans for locally advanced and metastatic genitourinary cancers. Facing a cancer diagnosis can be difficult for patients and their families. Please feel free to email to help you and your family (E-mail: SIMON.KIM@CUANSCHUTZ.EDU).

Care Philosophy
I am a Professor of Urologic Oncology and treat localized and locally advanced prostate, kidney, bladder, testicular, and penile cancer. Being diagnosed with cancer can be difficult for patients and their families. I strive to provide the highest quality and compassionate care for patients diagnosed with cancer and their family members. I perform robotic, open and laparoscopic surgery for bladder, kidney, prostate, testicular, penile and adrenal cancer. I previously served as Director of Robotic Surgery and Director of Kidney and Bladder Cancer at his prior faculty position. I focus on developing an individualized treatment plan that involves patients and their families to achieve the best possible outcome. I also collaborate with medical oncologists and radiation oncologists to develop a multidisciplinary treatment plan if needed. My family members have been diagnosed with cancer. I understand that this can be stressful. I will work with you and your family members to get the best treatment plan and outcomes. Please feel free to e-mail if I can help in anyway (E-mail: SIMON.KIM@CUANSCHUTZ.EDU)

Public Speaking
Yes
Prostate cancer screening and treatment decisions, outcomes research for genitourinary cancers, shared decision-making.

General Information

Medical Schools:
  • MD, Chicago Medical School at Rosalind Franklin University of Medicine & Science (2004)
Graduate Schools:
  • MPH, University of Illinois At Chicago (1997)
Undergraduate Schools:
  • BA, University of Rochester (NY) (1995)
Internships:
  • University of Michigan Hospitals and Health Centers Program (2005)
Residency Programs:
  • University of Michigan Hospitals and Health Centers Program, Chief Resident, Urology (2010)
Fellowships:
  • College of Medicine, Mayo Clinic (Rochester) Program, Urologic Oncology (2013)
Download CV
Languages: English
Department: Surgery-Urology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;